Even with becoming manufactured for less than $five a month, copyright carries a retail selling price that's hard to justify. The numerous hole among generation fees and pricing raises important questions on the pharmaceutical market's pricing strategies.California biotech behemoth Amgen ditched ideas for an experimental weight loss capsule in May